Related Experiment Video
Updated: Oct 29, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Particulate matter exposure is highly correlated to pediatric asthma exacerbation
Xin Yang1, Yuanyuan Zhang1, Xueqin Zhan1
1Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou 310052, China.
Insights
Particulate matter (PM) exposure is linked to increased pediatric asthma visits, particularly in young children. PM worsens allergic airway inflammation, suggesting Interleukin-33 (IL-33) as a potential therapeutic target for asthma exacerbation.
Area of Science:
- Environmental Health
- Pediatric Pulmonology
- Immunology
Background:
- Environmental factors significantly influence asthma's heterogeneity and severity.
- Particulate matter (PM) is increasingly recognized for its role in asthma exacerbation.
- Understanding the mechanisms linking PM exposure to pediatric asthma is crucial.
Purpose of the Study:
- To investigate the correlation between ambient PM concentrations and pediatric asthma exacerbation.
- To explore the underlying biological mechanisms of PM-induced asthma exacerbation.
- To identify potential therapeutic targets for mitigating PM's impact on pediatric asthma.
Main Methods:
- Analysis of a large cohort of pediatric asthma visits (N=16,779,739) linked to local PM data (2013-2017).
- Establishment of a house dust mite (HDM)-induced allergic airway inflammation mouse model with PM intervention.
- Assessment of the role of IL-33 in PM-aggravated airway inflammation using neutralizing antibodies.
Main Results:
- A significant correlation was found between higher PM concentrations and increased pediatric asthma visits, especially in children under 6 years old.
- PM exposure exacerbated HDM-induced allergic airway inflammation in the animal model.
- Administration of an IL-33 neutralizing antibody demonstrated a protective effect against PM-induced exacerbation.
Conclusions:
- Particulate matter is identified as a significant risk factor contributing to pediatric asthma exacerbation.
- The study highlights the role of IL-33 in the inflammatory response to PM in asthma.
- IL-33 emerges as a potential therapeutic target for managing PM-related pediatric asthma.
Abstract:
Asthma is a heterogeneous disease in which environmental factors play an important role, and the effect of particulate matter (PM) on the occurrence and severity of asthma is drawing more attention. This study aims to identify the correlation between PM and pediatric asthma exacerbation and explore the potential mechanisms. The asthma visits data (N = 16,779,739) in a university-based tertiary children's hospital from January 2013 to December 2017 were collected, and the relationship between asthma visits and local PM concentration was analyzed. For further study, we established a house dust mite (HDM)-induced allergic airway inflammation model with PM intervention. We detected a correlation between PM concentration and pediatric asthma visits, especially in children under 6 years old. The in vivo data showed that PM aggravated HDM-induced airway inflammation, and IL-33 neutralizing antibody exerted a protective role. Our study suggests that PM is a risk factor in promoting pediatric asthma exacerbation, in which IL-33 might be a promising target.
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

